doi: 10.1159/000407513.
(-)-Deprenyl leads to prolongation of L-dopa efficacy in Parkinson's disease
- PMID: 6408405
- DOI: 10.1159/000407513
Item in Clipboard
(-)-Deprenyl leads to prolongation of L-dopa efficacy in Parkinson's disease
Mod Probl Pharmacopsychiatry.
1983.
No abstract available
Similar articles
-
L-deprenyl treatment of on-off phenomena in Parkinson's disease.J Neural Transm. 1978;43(3-4):253-62. doi: 10.1007/BF01246962. J Neural Transm. 1978. PMID: 745018 No abstract available.
-
Experiences with L-deprenyl in Parkinsonism.J Neural Transm. 1978;43(3-4):263-9. doi: 10.1007/BF01246963. J Neural Transm. 1978. PMID: 370348 Clinical Trial.
-
(-)Deprenyl in the treatment of decompensated Parkinson's disease.J Neural Transm Suppl. 1986;22:247-52. J Neural Transm Suppl. 1986. PMID: 3097259
-
Selegiline in the treatment of Parkinson's disease.Acta Neurol Scand Suppl. 1989;126:103-11. doi: 10.1111/j.1600-0404.1989.tb01789.x. Acta Neurol Scand Suppl. 1989. PMID: 2515715 Review.
-
Deprenyl as symptomatic therapy in Parkinson's disease.Clin Neuropharmacol. 1988 Oct;11(5):387-400. doi: 10.1097/00002826-198810000-00001. Clin Neuropharmacol. 1988. PMID: 3146432 Review. No abstract available.
Cited by
-
Xanthoangelol and 4-Hydroxyderricin Are the Major Active Principles of the Inhibitory Activities against Monoamine Oxidases on Angelica keiskei K.Biomol Ther (Seoul). 2013 May 30;21(3):234-40. doi: 10.4062/biomolther.2012.100. Biomol Ther (Seoul). 2013. PMID: 24265870 Free PMC article.
-
Basic cell physiological activities (cell adhesion, chemotaxis and proliferation) induced by selegiline and its derivatives in Mono Mac 6 human monocytes.J Neural Transm (Vienna). 2012 May;119(5):545-56. doi: 10.1007/s00702-011-0735-1. Epub 2011 Nov 16. J Neural Transm (Vienna). 2012. PMID: 22086140
-
Synergistic interactions between COMT-/MAO-inhibitors and L-Dopa in MPTP-treated mice.J Neural Transm Gen Sect. 1995;102(1):19-34. doi: 10.1007/BF01276562. J Neural Transm Gen Sect. 1995. PMID: 8785021
-
The Neurotoxin l-Methyl-4-Phenyl-l,2,3,6-Tetrahydropyridine (MPTP): A Key to Parkinson's Disease?Pharm Res. 1986 Feb;3(1):7-11. doi: 10.1023/A:1016312629652. Pharm Res. 1986. PMID: 24271351
-
90 years of monoamine oxidase: some progress and some confusion.J Neural Transm (Vienna). 2018 Nov;125(11):1519-1551. doi: 10.1007/s00702-018-1881-5. Epub 2018 Apr 10. J Neural Transm (Vienna). 2018. PMID: 29637260 Review.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical